Table 3 The results of American Orthopaedic Foot and Ankle Society (AOFAS) score and its variation after treatment by trauma history and MRI grade within each group.

From: Combined Therapy with Shock Wave and Retrograde Bone Marrow-Derived Cell Transplantation for Osteochondral Lesions of the Talus

Parameter

n

Pre-treatment

Post-treatment

Variation

P 3 value

Group A (n = 41)

Hepple MRI Grade

 Grade I

11

53.4 ± 10.1

91.3 ± 12.6

38.1 ± 11.9

0.634

 Grade II

24

50.2 ± 12.6

88.5 ± 10.2

37.9 ± 10.4

 

 Grade III

6

48.9 ± 8.4

87.8 ± 9.1

38.3 ± 12.1

 

 P 1 value

 

0.073

0.068

  

Trauma History

 Trauma

26

49.3 ± 13.1

90.7 ± 12.8

41.3 ± 12.2

0.046

 No trauma

15

52.7 ± 10.9

87.9 ± 11.9

36.1 ± 10.9

 

 P 2 value

 

0.049

0.103

  

 Group B (n = 28)

 Hepple MRI Grade

 

52.3 ± 12.1

79.1 ± 10.6

  

 Grade I

8

51.1 ± 9.7

82.3 ± 8.1

32.1 ± 9.3

0.297

 Grade II

18

53.5 ± 13.6

80.6 ± 12.0

27.7 ± 12.4

 

 Grade III

2

47.5 ± 2.1

77.0 ± 1.4

29.5 ± 3.5

 

 P 1 value

 

0.096

0.118

  

Trauma History

 Trauma

19

51.9 ± 12.6

82.5 ± 13.3

32.7 ± 12.9

0.072

 No trauma

9

52.7 ± 11.7

78.6 ± 11.4

27.3 ± 12.1

 

 P 2 value

 

0.106

0.074

  
  1. Note: P 1 value: comparison of data among Hepple MRI Grade groups for AOFAS score of pre-treatment and post-treatment. P 2 value: comparison of data between trauma group and no trauma group for AOFAS score of pre-treatment and post-treatment. P 3 value: comparison of data by trauma history and MRI grade for peri-treatment AOFAS score variation.